a public good project by the
Synthesis
Company
of California

© 2026

Nicolae Hâncu | doi.page

0 works0 citations0 h-index

Nicolae Hâncu

Clinical Trial Investigators(US)

Publications by Year

Research Areas

Diabetes, Cardiovascular Risks, and Lipoproteins, Diabetes Management and Research, Diabetes Treatment and Management, Metabolism, Diabetes, and Cancer, Diet and metabolism studies

Most-Cited Works

→ Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial(2019)2,888 cited
→ Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial(2019)610 cited
→ Multifaceted Determinants for Achieving Glycemic Control(2008)290 cited
→ Insulin detemir and insulin aspart: a promising basal-bolus regimen for type 2 diabetes(2004)198 cited
→ Design and baseline characteristics of participants in the R esearching cardiovascular E vents with a W eekly IN cretin in D iabetes ( REWIND ) trial on the cardiovascular effects of dulaglutide(2017)184 cited
→ The effect of dulaglutide on stroke: an exploratory analysis of the REWIND trial(2020)140 cited

→ Prevalence of diabetes mellitus and prediabetes in the adult Romanian population: PREDATORR study(2015)

140 cited

→ Current practice in identifying and treating cardiovascular risk, with a focus on residual risk associated with atherogenic dyslipidaemia(2016)100 cited

→ A review of the evidence on reducing macrovascular risk in patients with atherogenic dyslipidaemia: A report from an expert consensus meeting on the role of fenofibrate–statin combination therapy(2015)83 cited

→ Prevalence of overweight/obesity, abdominal obesity and metabolic syndrome and atypical cardiometabolic phenotypes in the adult Romanian population: PREDATORR study(2016)75 cited